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Inﬂexinol, an ent-kaurane diterpenoid, was isolated from the leaves of Isodon excisus. Many diterpenoids isolated from the genus
Isodon (Labiatae) have antitumor and antiinﬂammatory activities. We investigated the antiinﬂammatory eﬀect of inﬂexinol in
RAW 264.7 cells and astrocytes. As a result, we found that inﬂexinol (1, 5, 10μM) suppressed the expression of inducible ni-
tric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) as well as the production of nitric oxide (NO) in LPS-stimulated RAW
264.7 cells and astrocytes. Consistent with the inhibitoryeﬀect on iNOS and COX-2 expression, inﬂexinol also inhibited transcrip-
tional and DNA binding activity of NF-κB via inhibition of IκB degradation as well as p50 and p65 translocation into nucleus.
These results suggest that inﬂexinol inhibits iNOS and COX-2 expression through inhibition of NF-κB activation, thereby in-
hibits generation of inﬂammatory mediators in RAW 264.7 cells and astrocytes, and may be useful for treatment of inﬂammatory
diseases.
Copyright © 2007 Jae Woong Lee et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Nitricoxide(NO),freeradicalproducedbytheinducibleNO
synthase (iNOS) isoform, is an essential component of the
host innate immune and inﬂammatory response to a vari-
ety of pathogens [1]. It has diverse physiological roles and
may also contribute towards pathological processes. When
NO is synthesized in large quantities by activated inﬂamma-
tory cells, it has cytotoxic properties and may be involved in
the pathogenesis of acute and chronic inﬂammatory condi-
tions [2]. In particular, NO is claimed to contribute to dam-
age of the joint cartilage in rheumatoid arthritis, to mucosal
injury in inﬂammatory bowel disease and to degeneration
of neurons in neurodegenerative diseases such as multiple
scleroses, Parkinson’s disease, and Alzheimer’s disease [3]. In
most neurodegenerative disorders, a massive neuronal cell
death occurs as a consequence of an uncontrolled inﬂam-
matory response, where activated astrocytes and microglia
and their cytotoxic agents play a crucial pathological role [4].
Glial cells consisting of astrocytes and microglia can produce
cytokines, reactive oxygen radicals, and NO in response to
ischaemic, traumatic, and infectious insults, leading to exag-
geration of the disease processes [5].
Coinduction or coregulation of cyclooxygenase-2 (COX-
2 )a n di N O Sh a v eb e e nd e m o n s t r a t e di nan u m b e ro f
cell culture studies and animal inﬂammatory model [6, 7].
Both COX-2 and iNOS are inducible form of enzymes up-
regulated in response to inﬂammation challenge. In inﬂam-
matory process, COX-2 is expressed in many cells including
ﬁbroblast and macrophages, and produces prostaglandins
that contribute to the pain and swelling of inﬂammation [8].
Expression of these inﬂammatory genes such as iNOS
and COX-2 can be regulated by the activation of the nuclear
factor-κB( N F - κB). Research of the literature reveals that
there are one NF-κB consensus DNA sequence within COX-
2p r o m o t e r[ 9], and two NF-κB DNA consensus sequences
within iNOS promoter [10] that are responsible for LPS-
induced NF-κB DNA binding activity. The most common
active form of the NF-κB family is the p50/p65 or p52/p65
heterodimer. In most cell types, inactive NF-κBc o m p l e x e s
are sequestered in the cytoplasm via their noncovalent inter-
action with inhibitory proteins known as IκBs. In response
to multiple stimuli, including cytokines, virus, and stress-
inducingagents,thelatentcytoplasmicNF-κB/IκBαcomplex
is activated by phosphorylation on conserved serine residues
in the N-terminal portion of IκB. After that, activated NF-κB2 Mediators of Inﬂammation
translocates to the nucleus and binds to its cognate DNA
binding site in the promoter or enhancer regions of speciﬁc
genes [11]. NF-κB is a major transcription factor that plays
an essential role in several aspects of human health including
the development of inﬂammation and immunity [12]. The
dysregulationofNF-κBisassociatedwithmanydiseasestates
suchasatherosclerosis,arthritis,cancer.Therefore,appropri-
ate regulation and control of NF-κB activity would provide
a potential approach for the management of NF-κB-related
human diseases [11].
Isodon excisus,n a m e dOh Ri Bang Pul in Korea, belongs
to the genus Isodon and is distributed in Korea and Japan.
The extracts have been used in fork medicine in Korea for
treating a bruise, inﬂammation and pain. The genus Isodon
(also called Rabdosia) is a rich source of diterpenes, espe-
cially the highly oxidized kaurene diterpenes. Ent-kaurene is
the main diterpene intermediate involved in the biosynthe-
sis of gibberellins, a widespread family of plant hormones
with isoprenoid structure that control various physiologi-
cal plant functions such as growth, germination, and ﬂow-
ering [13]. Some kaurene ditrerpene compounds have been
demonstrated to exhibit not only cytotoxic activity against
variouscancercelllinesbutalsoinhibitoryactivityoftheNF-
κBp a t h w a yi nm a c r o p h a g e s[ 14–16]. For example, Linearol,
a kaurene diterpene that impaired the inﬂammatory signal-
ingbyinhibitingNF-κBinducingkinaseinLPS-inducedJ774
macrophages [17]. Kamebakaurin, another kaurane diter-
pene also inhibited TNF-α-induced NF-κB activation by di-
rectcovalentmodiﬁcationofcysteine62inthep50inMCF-7
cells [18]. Therefore, much interest has recently been shown
in the biological eﬀects of kaurene diterpenes.
In the present study, we investigated antiinﬂammatory
activity of inﬂexinol and its possible mechanisms in cultured
RAW 264.7 cells and astrocytes. Inﬂexinol inhibited LPS-
induced NO production as well as LPS-induced expression
ofiNOSandCOX-2inRAW264.7cellsandastrocytes.Using
gel shift assay and NF-κB luciferase assay, we showed that in-
ﬂexinol inhibited activation of the transcriptional factor NF-
κB, a central regulator of iNOS and inﬂammatory response
of body. These our data provide evidence that inﬂexinol has
inhibitory eﬀect on NO production through inhibition of
NF-κB activation. These results suggest that inﬂexinol can be
used for an antiinﬂammatory agent.
2. MATERIALS AND METHODS
2.1. Chemicalsandreagents
Inﬂexinol (Figure 1) was isolated from Isodon excisus (Labi-
atae). The dried aerial parts of I. excisus (1.6kg) were pul-
verized and extracted with MeOH (3 × 1.5L)atroomtem-
perature (24 hours). The extract was ﬁltered and concen-
trated, in vacau and suitably diluted with water, then par-
titioned with n-hexane (3 × 1.5L) and CH2Cl2 (3 × 1.5L),
respectively. The CH2Cl2 extract (13.7g) was subjected to
column chromatography on silica gel (9 × 25cm, 70–230
mesh) eluting with n-hexane-acetone (5 : 1, 3 : 1, 3 : 2,
acetone) aﬀording ﬁve fractions (IEC-1 ∼ IEC-5). Fraction
AcO
AcO
OH
H
H
OH
O
Figure 1: Chemical structure of inﬂexinol (ent-1β,3α,6β,11α-
tetrahydroxykaur-16-ene-15-one 3,11-diacetate).
IEC-3 was subjected to ﬂash column chromatography on
RP-18 (2 × 30cm, 40–63μm) eluting with CH3CN : H2O
(30 : 70) and semiprepatative HPLC (column: YMC-ODC,
20 × 150mm) eluting with CH3CN : H2O (23 : 77) at the
ﬂow speed of 6.5mL/min. The structure of this compound
was determined as ent-1β,3α,6β,11α-tetrahydroxykaur-16-
ene-15-one-3,11-diacetate (inﬂexinol), by comparison of its
physicochemical and spectral data with those of literature
[19].
LPS was obtained from Sigma Aldrich (St Louis, Mo,
USA) Dulbecco’s modiﬁed Eagle’s medium (DMEM), fetal
bovine serum, penicillin, and streptomycin were purchased
from Invitrogen (Carlsbad, Calif, USA).
2.2. RAW264.7cellculture
RAW 264.7 cells were obtained from the American Type Cul-
tureCollection(Rockville,Md,USA).Thesecellsweremain-
tained at subconﬂuence in a 95% air, 5% CO2 humidiﬁed at-
mosphere at 37◦C. The medium used for routine subcultiva-
t i o nw a sD u l b e c c o ’ sM o d i ﬁ e dE a g l e ’ sM e d i u m( D M E M ,I n -
vitrogen, Carlsbad, Calif, USA), supplemented with 10% fe-
tal bovine serum (FBS), penicillin (100units/mL), and strep-
tomycin (100μg/mL). Cells were counted with a hemocy-
tometer and the number of viable cells was determined
through trypan blue dye exclusion.
2.3. Astrocyteculture
TheSprague-Dawleyratsweremaintainedinaccodancewith
the policy of the National Institute of Toxicological research,
which is in accord with the Korea Food and Drug Adminis-
tration’s guideline for the care and use of laboratory animals.
Sprague-Dawley rats weighing 200–300g were housed under
12-hour light/dark cycles, at 23◦C, and 60 ± 5% humidity.
All animals had free access to food (Samyang Foods, Seoul,
South Korea) and water. Cerebral cortical cells were isolated
from neonatal rat brain (day 1) in PBS (0.1mol). After wash-
ing with Dulbecco’s modiﬁed Eagle’s medium (DMEM), the
isolated cells were incubated for 15 minutes in DMEM con-
taining 0.2% trypsin. Cells were dissociated by trituration
and plated into polyethyleneimine-coated plastic (5 × 105
cells/60mm dish) containing minimum essential mediumJ a eW o o n gL e ee ta l . 3
with Eagle’s salts supplemented with 10% heat-inactivated
fetal bovine serum, 2mM L-glutamine, 1mM pyruvate,
20mM KCl, 10mM sodium bicarbonate, and 1mM Hepes
(pH 7.2). After 3 days in culture, the culture medium was re-
placed with DMEM containing 10% fetal bovine serum, and
medium was changed every 3 days of culture. Cells were cul-
turedfordesignatedtime.Theculturedcellscontained<10%
neuronal cells.
2.4. Cellviabilityassay
The cytotoxicity of inﬂexinol was evaluated using the
WST-8 assay (Dojindo Laboratories, Tokyo, Japan). WST-
8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium, monosodium salt] is re-
duced by dehydrogenases in cells to give a yellow-colored
product (formazan), which is soluble in the culture medium.
The amount of the formazan dye generated by the activity of
dehydrogenases in cells is directly proportional to the num-
ber of living cells. In brief, 1 × 104 cells per well were plated
into96-wellplates,incubatedat37◦Cfor24hours,andgiven
a fresh change of medium. Cells were then incubated with
or without LPS (1μg/mL) in the absence or presence of var-
ious concentrations of inﬂexinol at 37◦C for an additional
24 hours. At that point, 10μl of the WST-8 solution were
added to the wells and incubation was continued for another
1hour.Theresultingcolorwasassayedat450nmusingami-
croplate absorbance reader (Sunrise, Tecan, Switzerland).
2.5. Nitriteassay
Cells were grown in 96-well plates and then incubated with
or without LPS (1μg/mL) in the absence or presence of vari-
ous concentrations of inﬂexinol for 24 hours. The nitrite ac-
cumulation in the supernatant was assessed by Griess reac-
tion [20]. Each 50μl of culture supernatant was mixed with
an equal volume of Griess reagent [0.1% N-(1-naphthyl)-
ethylenediamine, 1% sulfanilamide in 5% phosphoric acid]
and incubated at room temperature for 10 minutes. The
absorbance at 540nm was measured in a microplate ab-
sorbance reader, and a series of known concentrations of
sodium nitrite was used as a standard.
2.6. Westernblotanalysis
Cells were homogenized with protein extraction solution
(PRO-PREP, Intron Biotechnology, South Korea), and lysed
by 40-minute incubation on ice. The lysate centrifuged at
15000rpm for 15 minutes. Equal amount of proteins (40μg)
wereseparatedonanSDS/10%-polyacrylamidegel,andthen
transferred to a polyvinylidene diﬂuoride (PVDF) mem-
brane (GE Water & Process technologies, Trevose, Pa, USA).
Blots were blocked for 2 hours at room temperature with
5% (w/v) nonfat dried milk in Tris-buﬀered saline Tween-
20 [TBST: 10mM Tris (pH 8.0) and 150mM NaCl solution
containing 0.05% Tween-20]. After a short wash in TBST,
the membrane was incubated at room temperature with spe-
ciﬁc antibodies. Rabbit polyclonal antibodies against iNOS
and COX-2 (1 : 1000) (Cayman Chemical, Ann Arbor, Mich,
USA), and rabbit polyclonal antibodies against p65 and IκBα
(1 : 500), and mouse monoclonal antibody against p50 (1 :
500) (Santa Cruz Biotechnology Inc. Santa Cruz, Calif, USA)
wereusedinstudy.Theblotwasthenincubatedwiththecor-
responding conjugated antirabbit or mouse immunoglobu-
linG-horseradishperoxidase(SantaCruzBiotechnologyInc.
Santa Cruz, Calif, USA). Immunoreactive proteins were de-
tected with the ECL western blotting detection system.
2.7. Gelelectromobilityshiftassay
Gel shift assays were performed according to the manufac-
turer’s recommendations (Promega, Madison, Wis, USA).
Brieﬂy, 5 × 106 cells was washed twice with 1× PBS, fol-
lowed by the addition of 1mL of PBS, and the cells were
scraped into a cold Eppendorf tube. Cells were spun down at
13000rpm for 5 minutes, and the resulting supernatant was
removed. Cells were suspended in 400μl of solution A con-
taining 10mM HEPES, pH 7.9, 1.5mM MgCl2,1 0m MK C l ,
0.5mM dithiothreitol, 0.2mM phenylmethylsulfonyl ﬂuo-
ride; vigorously vortexed; allowed to incubate on ice for 10
minutes; and centrifuged at 12000rpm for 6 minutes. The
pelleted nuclei were resuspended in solution C (solution A +
420mM NaCl, 20% glycerol) and allowed to incubate on ice
for 20 minutes. The cells were centrifuged at 15000rpm for
15minutes,andtheresultingnuclearextractsupernatantwas
collected in a chilled Eppendorf tube. Consensus oligonu-
cleotides were end-labeled using T4 polynucleotide kinase
and [γ-32P] ATP for 10 minutes at 37◦C. Gel shift reactions
were assembled and allowed to incubate at room tempera-
ture for 10 minutes followed by the addition of 1μl (50000–
200000cpm)of 32Pend-labeledoligonucleotideandanother
20minutesofincubationatroomtemperature.Subsequently
1μl of gel loading buﬀer was added to each reaction and
loaded onto a 6% nondenaturing gel and electrophoresis un-
til the dye was four-ﬁfths of the way down the gel. The gel
was dried at 80◦C for 1 hour and exposed to ﬁlm overnight
at 70◦C.
2.8. TransfectionandasssyofNF-κBluciferaseactivity
RAW 264.7 cells and astrocytes were plated at a density of
1 × 105 cells per 24-well plate. After 24 hours of growth to
90% conﬂuence, the cells were transfected with pNF-κB-Luc
plasmid (5× NF-κB; Stratagene, Calif, USA) using a mix-
ture of plasmid and lipofectAMINE PLUS in OPTI-MEN ac-
cordingtomanufacture’sspeciﬁcation(Invitrogen,Carlsbad,
Calif, USA). Luciferase activity was measured by using the
luciferase assay kit (Promega, Madison, Wis, USA) according
to the manufacturer’s instructions (WinGlow, Bad Wildbad,
Germany).
2.9. Statisticalevaluation
The data represent the mean ± (SE) of three independent
experiments performed in triplicate. Statistical analysis was
performed by one-way ANOVA, followed by a Dunnett test
as post hoc comparison. Diﬀerences were considered signiﬁ-
cant at P<. 05.4 Mediators of Inﬂammation
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Figure 2: Eﬀect of inﬂexinol on viability of RAW 264.7 cells (a) and (b) and astrocytes (c), (d). The cell viability was evaluated using a
WST-8 assay. Cells were incubated with inﬂexinol in the absence of LPS (a) and (c) and incubated with inﬂexinol in the presence of LPS (b)
and (d). Results were given in percent related to untreated controls. The data represent the mean ± (SE) of three independent experiments
performed in triplicate.
3. RESULTS
3.1. EffectofinﬂexinoloncellviabilityinRAW264.7
cellsandastrocytes
After RAW 264.7 cells were incubated with inﬂexinol in the
absence of LPS, inﬂexinol increased slightly cell viability at
lower concentrations (1, 5μM) and showed mild reduction
(<20%) of cell viability at highest concentration (10μM)
used (Figure 2(a)). When RAW 264.7 cells were incubated
with inﬂexinol in the presence of LPS, LPS remarkably in-
creased the cell viability. Although mild reduction of cell vi-
ability (<20%) was showed by 10μM of inﬂexinol like pre-
vious case, it is considered that inhibitory eﬀect of inﬂam-
matory mediators by inﬂeixnol is not related with cytotoxic
eﬀect (Figures 2(b)).
Moreover, inﬂexinol (with or without LPS) did not de-
crease the cell viability at the various concentrations (1, 5,
10μM)usedinastrocyteswhetherinﬂexinolwastreatedwith
or without LPS (Figures 2(c) and 2(d)).
3.2. Effect of inﬂexinol on LPS-induced NO production
andiNOSandCOX-2expressioninRAW264.7cells
andastrocytes
We have examined the inhibitory eﬀect of inﬂexinol on NO
production of RAW 264.7 cells and astrocytes induced by
LPS (1μg/mL). To evaluate the eﬀect of inﬂexinol on NO
production in LPS-induced RAW 264.7 cells and astrocytes,
nitrite accumulation was examined by the Griess assay. Af-
ter co-treatment with LPS and inﬂexinol (1, 5, 10μM) for
24 hours, LPS-induced nitrite concentrations in the medium
were decreased remarkably in a concentration-dependent
manner. In RAW 264.7 cells (Figure 3(a))a n da s t r o c y t e s
(Figure 3(b)),theIC50 valuesofinﬂexinoloninhibiting LPS-
induced NO production were 3.43μM and 2.66μM, respec-
tively.
To investigate whether inﬂexinol inhibits the NO pro-
duction via inhibition of corresponding gene expression, we
determined iNOS expression by Western blot analysis. We
also determined COX-2 expression since iNOS can be mod-
ulated by COX-2. As shown in Figures 3(c) and 3(d), the
cells expressed extremely low levels of iNOS and COX-2
protein in an unstimulated condition. However, iNOS and
COX-2 protein expression was markedly increased in re-
sponse to LPS (1μg/mL) after 24 hours. Treatment with in-
ﬂexinol (1, 5, 10μM) caused concentration-dependent de-
creases in LPS-induced iNOS expression in RAW 264.7 cells
(Figure 3(c))a n da s t r o c y t e s( Figure 3(d)). This result is con-
sistent with the proﬁle of the inhibitory eﬀect of inﬂexinol
on NO production. A similar inhibitory eﬀect of inﬂexinol
on the LPS-induced COX-2 expression was found (Figures
3(c) and 3(d)).J a eW o o n gL e ee ta l . 5
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Figure 3: Eﬀect of inﬂexinol on LPS-induced nitrite production in RAW 264.7 cells (a) and astrocytes (b). The cells were treated with
1μg/mL of LPS only or LPS plus diﬀerent concentrations (1, 5, 10μM) of inﬂexinol at 37◦C for 24 hours. NO generation was determined in
culture medium as described in Section 2. The data represent the mean ± (SE) of the three independent experiments performed in triplicate.
∗ indicates signiﬁcantly diﬀerent from the LPS-treated group (P<. 05). Eﬀect of inﬂexinol on the protein expression of iNOS and COX-2 in
RAW 264.7 cells (c) and astrocytes (d). The cells were treated with 1μg/mL of LPS only or LPS plus diﬀerent concentrations (1, 5, 10μM) of
inﬂexinol at 37◦C for 24 hours. Equal amounts of total proteins (40μg/lane) were subjected to 10% SDS-PAGE, and the expression of iNOS
and COX-2 was dectected by Western blotting using speciﬁc antibodies. β-actin protein was used here as an internal control. Similar results
were obtained from at least three diﬀerent sets of experiment.
3.3. EffectofinﬂexinolonNF-κBluciferaseactivity
NF-κB controls the expression of enzymes including iNOS
and COX-2 whose products contribute to the pathogenesis
of the inﬂammatory process [20]. To investigate whether in-
ﬂexinol is able to attenuate LPS-induced NF-κB-mediated
promoter activity, we used a luciferase reporter gene ex-
pressedunderthecontrolofﬁveκBcis-actingelements.RAW
264.7 cells and astrocytes were transiently transfected with
the NF-κB-dependent luciferase reporter construct accord-
ing to manufacture’s speciﬁcation (Invitrogen), and then cell
treated with LPS (1μg/mL) or cotreated with LPS and inﬂex-
inol for 8 hours. Treatment of RAW 264.7 cells (Figure 4(a))
and astrocytes (Figure 4(b)) with inﬂexinol resulted in a
dose-dependent suppression of luciferase activity induced by
LPS. In RAW 264.7 cells and astrocytes, the IC50 values of
inﬂexinol on inhibiting LPS-induced luciferase activity were
2.77μM and 3.88μM, respectively. These doses inhibiting
NF-κB luciferase activity were similar to the doses inhibiting
NO production.
3.4. EffectofinﬂexinolonNF-κBDNAbindingactivity
Because activation of NF-κB is critical for induction of both
COX-2 and iNOS by LPS or other inﬂammatory cytokines,
we determined whether inﬂexinol might suppress NF-κBa c -
tivation in LPS-activated RAW 264.7 cells and astrocytes. To
investigate whether inﬂexinol can also inhibit NF-κBa c t i -
vation, RAW 264.7 cells and astrocytes were cotreated with
LPS and inﬂexinol for 60 minutes and 90 minutes, respec-
tively, which it is the time to activate NF-κB maximally of
its LPS treatment (data are not shown). Nuclear extracts
from cotreated cells were prepared and assayed NF-κBD N A6 Mediators of Inﬂammation
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Figure 4: Eﬀect of inﬂexinol on LPS-induced NF-κB-dependent luciferase activity in RAW 264.7 cells (a) and astrocytes (b). RAW 264.7
cells and astrocytes were transfected with p-NF-κB-Luc plasmid (5× NF-κB), and then treated with LPS (1μg/mL) alone or with inﬂexinol
( 1 ,5 ,1 0μM) for 37◦C for 8 hours. Luciferase activity was then determined as described in Section 2. Values represent the mean ± (SE)
of three independent experiments with triplicate, and each luciferase activity was calibrated by amount of protein. ∗ indicates signiﬁcantly
diﬀerent from the LPS-treated group (P<. 05). Eﬀect of inﬂexinol on LPS-induced NF-κB DNA binding activity in RAW 264.7 cells (c)
and astrocytes (d). The activation of NF-κB was investigated using EMSA as described in Section 2. Nuclear extracts from RAW 264.7 cells
a n da s t r o c y t e sw i t hL P Sa l o n e( 1μg/mL) or with inﬂexinol (1, 5, 10μM) were subjected to DNA binding reaction with 32P end-labeled
oligonucleotide speciﬁc to NF-κB. Speciﬁc DNA binding of NF-κB complex is indicated by an arrow. Similar results were obtained from at
least three diﬀerent sets of experiment.
binding by EMSA. In RAW 264.7 cells (Figure 4(c))a n da s -
trocytes (Figure 4(d)), LPS induced a strong NF-κB binding
activity, which was markedly inhibited by cotreatment with
inﬂexinol in a dose-dependent manner.
3.5. EffectofinﬂexinolonLPS-inducedp50/p65
translocationanddegradationofIκB
It has been demonstrated that LPS activates NF-κBt r a n -
scription factor that leads to the induction of the expres-
sion of many immediate early genes [21]. To clarify the in-
hibitory mechanism of action of inﬂexinol for LPS-induced
NF-κB, translocation of p50 and p65 as well as IκBα degra-
dation were examined. Treatment with LPS increased nu-
clear translocation of p50 and p65. In the presence of inﬂex-
inol, nuclear translocation of p50 and p65 was inhibited in a
dose-dependent manner in RAW 264.7 cells and astrocytes.
Moreover, inﬂexinol inhibited the LPS-induced degradation
of IκBα (Figures 5(a) and 5(b)). These results indicate that
inﬂexinol may inhibit the LPS-induced activation of NF-κB
via an inhibition of IκBα d e g r a d a t i o na sw e l la sat r a n s l o -
cation of p50 and p65 into the nuclear, and this eﬀect may
result in the inhibition of the LPS-induced NO production
as well as iNOS and COX-2 expression.J a eW o o n gL e ee ta l . 7
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Figure 5: Eﬀect of inﬂexinol on LPS-induced NF-κB activity and degradation of IκB in RAW 264.7 cells (a) and astrocytes (b). The cell
treated with 1μg/mL of LPS only or LPS plus diﬀent concentrations (1, 5, 10μM) of inﬂexinol at 37◦C for 1 hour. Equal amounts of total
protein (40μg) were subjected to 10% SDS-PAGE. Nuclear translocation of p50 and p65, and degradation of IκB were detected by Western
blotting using speciﬁc antibodies. β-actin protein was used here as an internal control. Similar results were obtained from at least three
diﬀerent sets of experiment.
4. DISCUSSION
Inﬂammatory processes play a critical role in the pathogene-
sis of many human diseases. Macrophage overproduction of
inﬂammatory mediators such as cytokine and NO has been
implicated in inﬂammatory diseases such as rheumatoid
arthritis, septic shock, cerebral malaria, and autoimmune di-
abetes [22]. Astrocytes play a key role in regulating aspects
of inﬂammation in the central nervous system. Several en-
zymes, such as the iNOS or COX-2, along with diﬀerent in-
ﬂammatory mediators such as the free radical NO or proin-
ﬂammatory cytokines, have been proposed to be involved in
the cell damage associated with neuroinﬂammation [23]. In
this study, we investigated the inhibitory eﬀects of inﬂexi-
nolonLPS-inducedNOproductionandexpressionofiNOS,
COX-2 in RAW 264.7 cells and astrocytes. Inﬂexinol (1, 5,
10μM) that signiﬁcantly inhibited LPS-induced NO produc-
tion in a dose-dependent manner. Inﬂexinol strongly inhib-
ited LPS-induced NO production in RAW 264.7 cells and
astrocytes with IC50 values of 3.43μM and 2.66μM, respec-
tively. These inhibitory eﬀects may not be related with their
cytotoxic eﬀects since no eﬀects on cell viability were ob-
served at the concentration up to 10μM in RAW 264.7 cells
andastrocytes.ComparisonwithIC50 valueofindomethacin
(53.8μM) and lornoxicam (65μM) being known as non-
steroidal antiinﬂammatory drugs in LPS-stimulated RAW
264.7 cells indicates that inﬂexinol has superior eﬀects on in-
hibition of NO production [24, 25].
This inhibitory eﬀect of NO production could be re-
lated with gene expression of iNOS since inﬂexinol inhibited
iNOS protein in RAW 264.7 cells and astrocytes. Inﬂexinol
also inhibited LPS-induced COX-2 expression. These results
showed that inﬂexinol could interfere LPS-induced signal-
ing involving the production of proinﬂammatory molecules.
However, our data showed that the expression of COX-2 was
found to be less sensitive than that of iNOS to the inﬂexinol.
This could account for the higher sensitivity of iNOS gene
transcription toward the inﬂexinol compared with that of
COX-2. In fact, structurally diﬀerent diterpenoids displayed
diﬀerential inhibition of iNOS and COX-2 expression even
though the DNA binding activity of NF-κB is similar [26].
Since LPS-induced iNOS and COX-2 expression is primarily
regulated by NF-κB, we examined the eﬀect of inﬂexinol on
LPS-induced activation of NF-κB using an NF-κBr e p o r t e r
system as well as DNA binding activity using EMSA. Consis-
tent with the inhibitory eﬀect on iNOS and COX-2 expres-
sion, inﬂexinol decreased NF-κB transcriptional activity in
RAW 264.7 cells and astrocyte with IC50 values of 2.77μM
and 3.88μM, respctively. Inﬂexinol also inhibited NF-κB-
speciﬁc DNA binding activity dose dependently. At the gene
level, the expression of iNOS is largely regulated by tran-
scriptional activation. The promoter of the iNOS gene con-
tains two major discrete regions synergistically functioning
for binding of transcription factors: one for NF-κB, which is
mainly activated by LPS [21] .T h e r ei sa l s oo n eN F - κBc o n -
sensus DNA sequence within COX-2 promoter. Therefore,
inhibition of NF-κB activation could contribute to the in-
hibitory eﬀect of inﬂexinol on iNOS and COX-2 expression.
Several studies have shown that antiinﬂammatory agents
inhibit activation of NF-κB via prevention of IκBd e g r a d a -
tion. IκBα speciﬁcally binds and masks the nuclear translo-
cation signals of p50 and p65, thereby preventing the nuclear
translocation of the NF-κB heterodimer. Hehner et al. have
showed that sesquiterpene lactones prevented the induced8 Mediators of Inﬂammation
degradation of IκBα and IκBβ by diverse stimuli and there-
fore interfered with a common step in the signaling cas-
cade leading to the activation of NF-κB[ 27]. Lee et al. have
also demonstrated that prevention of IκBd e g r a d a t i o nb y
2 -hydroxycinnamaldehyde contributed to inactivation of
NF-κB (p50) in antiinﬂammatory reaction in RAW 264.7
cells [28]a sw e l la sT N F - α-treated colon cancer cell death
[29].
The way that inﬂexinol can interfere with NF-κBa c t i -
vation is not clear. However, it is noteworthy that inﬂex-
inol contains an α-methylenecyclopentanone moiety as a
commom functional group which is known to react with
nucleophiles, especially cystein sulfhydryl groups in pro-
tein, by a Michael-type addition. A C-20-nonoxygenated-
ent-kaurane diterpenoid (kamebakaurin, KA), isolated from
Isodon japonicus, was suggested to interact with cysteine of
DNA binding domain of the p50 subunit of NF-κB[ 15]. Re-
cently, KA was found to be able to interact with both p50 and
p65 subunits of NF-κB[ 26]. Hehner et al. also demonstrated
that sesquiterpene lactones interfered with the activation of
NF-κB by preventing a degradation of IκBα and IκBβ but
lacking either the lactone or the exomethylene group in the
α-position to the lactone function displayed no inhibitory
eﬀect on pathway leading to the activation of NF-κB[ 27].
Similarly, the exomethylene group of inﬂexinol may be es-
sential for the covalent modiﬁcation via interaction with cys-
teine as above compounds. Moreover, data presented herein
show that inﬂexinol signiﬁcantly inhibits NF-κBa c t i v a t i o n
byreducingthedegradationofIκB. Kwok et al. have reported
that exocylic methylene of sesquiterpene lactone partheno-
lide is required for in vivo and in vitro antiinﬂammatory
activity and modiﬁcation of cysteine 179 of IKKβ has been
proposed to mediate the pathological eﬀects of arsenite and
parthenolide [30]. Therefore, our data suggest a possibility
that inﬂexinol inhibit the upstream proteins of IκBs u c ha s
IKK or 26s proteasome. This issue is being currently investi-
gated.
On the basis of the current results and those of other
reports, we propose that inﬂxinol inhibit the expression of
iNOS, COX-2, and NO production by inhibition of NF-κB
DNA binding activity and transcriptional activation through
prevention of IκB degradation, and suggest that inﬂexinol
may be useful as an antiinﬂammatory agent.
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